Taxonomy Viewer

RJ 655 - Healthcare institutions

Browse through 12,486,109 XBRL objects!

Taxonomy Viewer

Statistics

XBRL Model Project

Arc name	presentationArc
Arc role	http://www.xbrl.org/2003/arcrole/parent-child
Link role	urn:rj:linkrole:annual-reporting-guidelines-655

Concept	Order
RJ 655 - Healthcare institutions `rj-abstr:AnnualReportingGuidelines655Title`
Reference to the available information on compliance with the codes of conduct `rj-i:ReferenceToTheAvailableInformationOnComplianceWithCodesOfConduct`	1
Description whether specific codes of conduct are mandatory or voluntary `rj-i:DescriptionWhetherSpecificCodesOfConductAreMandatoryOrVoluntary`	2
Description of specific codes of conduct are followed and which codes of conduct are concerned `rj-i:DescriptionSpecificCodesOfConductFollowedAndWhichCodesOfConductAreConcerned`	3
Description of the principal risks and uncertainties relating to carrying out self-tests `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToCarryingOutSelfTests`	4
Description of the principal risks and uncertainties relating to special cost developments (eg expensive medicines) `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToSpecialCostDevelopments`	5
Description of the principal risks and uncertainties relating to bed reduction in mental health care `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToBedReductionInMentalHealthCare`	6
Description of the principal risks and uncertainties relating to developments in the macro framework `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToDevelopmentsMacroFramework`	7
Description of the principal risks and uncertainties relating to revenue recognition `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToRevenueRecognition`	8
Description of the principal risks and uncertainties relating to contracting of care and performance-related funding `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToContractingCarePerfomanceRelatedFunding`	9
Description of the principal risks and uncertainties relating to property valuation including impairments `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToPropertyValuationIncludingImpairments`	10
Difference in result in the separate and consolidated financial statements `jenv-bw2-i:ResultDifferenceSeparateConsolidatedFinancialStatements`	11
Social security contributions `jenv-bw2-i:SocialSecurityContributions`	12
Result in the consolidated financial statements `jenv-bw2-i:ResultConsolidatedFinancialStatements`	13
Result in the separate financial statements `jenv-bw2-i:ResultSeparateFinancialStatements`	14
Assets `jenv-bw2-i:Assets`	15
Non-current assets `jenv-bw2-i:AssetsNoncurrent`	16
Intangible assets `jenv-bw2-i:IntangibleAssets`	17
Property, plant and equipment `jenv-bw2-i:PropertyPlantEquipment`	18
Financial assets `jenv-bw2-i:FinancialAssets`	19
Current assets `jenv-bw2-i:AssetsCurrent`	20
Inventories `jenv-bw2-i:Inventories`	21
Gross DBCs and DBC-healthcare products in progress `rj-i:DBCsDBCHealthcareProductsInProgressGross`	22
Receivables relating to financing deficit `rj-i:ReceivablesFinancingDeficit`	23
Trade and other receivables `rj-i:TradeOtherReceivables`	24
Current securities `jenv-bw2-i:SecuritiesCurrent`	25
Cash and cash equivalents `jenv-bw2-i:CashAndCashEquivalents`	26
Equity and liabilities `jenv-bw2-i:EquityAndLiabilities`	27
Equity `jenv-bw2-i:Equity`	28
Foundation capital `rj-i:FoundationCapital`	29
Designated funds `rj-i:DesignatedFunds`	30
Designated reserves `rj-i:DesignatedReserves`	31
General and other reserves `rj-i:GeneralOtherReserves`	32
Provisions `jenv-bw2-i:Provisions`	33
Non-current liabilities `jenv-bw2-i:LiabilitiesNoncurrent`	34
Current liabilities `jenv-bw2-i:LiabilitiesCurrent`	35
Current liabilities relating to financing surplus `rj-i:LiabilitiesFinancingSurplusCurrent`	36
Other current liabilities `rj-i:LiabilitiesCurrentOther`	37
Operating income `jenv-bw2-i:OperatingIncome`	38
Subsidy income `rj-i:SubsidyIncome`	39
Income from care services and social support `rj-i:IncomeFromCareServicesAndSocialSupport`	40
Other operating income `jenv-bw2-i:OperatingIncomeOther`	41
Operating expenses `jenv-bw2-i:OperatingExpenses`	42
Amortisation of intangible assets and depreciation of property, plant and equipment `jenv-bw2-i:DepreciationPropertyPlantEquipmentAmortisationIntangibleAssets`	43
Impairment of non-current assets `rj-i:ImpairmentAssetsNoncurrent`	44
Expenses for fees of independent medical specialists `rj-i:ExpensesFeesIndependentMedicalSpecialists`	45
Other operating expenses `jenv-bw2-i:OperatingExpensesOther`	46
Operating result `jenv-bw2-i:OperatingResult`	47
Financial income and expenses `rj-i:FinancialIncomeExpenses`	48
Result `rj-i:Result`	49
DBCs and DBC-healthcare products in progress (assets) `rj-i:DBCsDBCHealthcareProductsInProgressAssets`	50
DBCs and DBC-healthcare products in progress (liabilities) `rj-i:DBCsDBCHealthcareProductsInProgressLiabilities`	51
Provision for DBCs and DBC-healthcare products in progress `rj-i:DBCsDBCHealthcareProductsInProgressProvision`	52
Advances received for DBCs and DBC-healthcare products in progress `rj-i:DBCsDBCHealthcareProductsInProgressBillings`	53
Net DBCs and DBC-healthcare products in progress `rj-i:DBCsDBCHealthcareProductsInProgressNet`	54
Equity `jenv-bw2-dm:EquityMember`	55
Foundation capital `rj-dm:FoundationCapitalMember`	56
Designated reserves `rj-dm:DesignatedReservesMember`	57
Designated funds `rj-dm:DesignatedFundsMember`	58
General and other reserves `rj-dm:GeneralOtherReservesMember`	59
Movement in equity during the period `jenv-bw2-i:EquityMovement`	60
Designated reserve `rj-i:DesignatedReserve`	61
Description of the amount and the specific purpose of the designated reserves, as well as the fact that the management has made this limitation `rj-i:DesignatedReserveDescription`	62
Designated fund `rj-i:DesignatedFund`	63
Description of the amount and specific purpose of the designated reserves, as well as the reason for this restriction and all other conditions set by third parties `rj-i:DesignatedFundDescription`	64
Group equity `jenv-bw2-i:EquityGroup`	65
Share in group equity not accrued to legal entity `jenv-bw2-i:NoncontrollingInterest`	66
Income health insurance act `rj-i:IncomeHealthInsuranceAct`	67
Income legal budget for acceptable costs Wlz `rj-i:IncomeLegalBudgetAcceptableCostsWlz`	68
Income Youth law `rj-i:IncomeYouthLaw`	69
Income WMO `rj-i:IncomeWMO`	70
Income Ministry of Securitty and Justice `rj-i:IncomeMinistryVenJ`	71
Income availability contributions Healthcare `rj-i:IncomeAvailabilityContributionsHealthcare`	72
Income from other care services `rj-i:IncomeCareServicesOther`	73
Subsidy income from central governments relating to Ministry of V&J `rj-i:SubsidyIncomeCentralGovernmentsMinistryVenJ`	74
Subsidy income from central governments relating to Ministry of VWS `rj-i:SubsidyIncomeCentralGovernmentsMinistryVWS`	75
Central government contributions relating to the workplace function and medical faculty of UMC's `rj-i:CentralGovernmentContributionsWorkplaceFunctionMedicalFacultyUMCs`	76
Other subsidy income from central governments `rj-i:SubsidyIncomeCentralGovernmentsOther`	77
Income availability contributions Education `rj-i:IncomeAvailabilityContributionsEducation`	78
Subsidy income relating to provinces and municipalities (excluding WMO and Youth law) `rj-i:SubsidyIncomeProvincesMunicipalitiesExcludingWMOYouthLaw`	79
Other subsidies, including wage cost subsidies and EU subsidies `rj-i:SubsidyIncomeOther`	80
Other services (including 2nd - 4th flow of UMCs for research) `rj-i:OperatingIncomeOtherServicesOther`	81
Other income (including compensation for loaned person and rental property) `rj-i:OperatingIncomeOtherIncomeOther`	82
Expenses of employee benefits `jenv-bw2-i:EmployeeBenefitsExpenses`	83
Wages `jenv-bw2-i:WagesSalaries`	84
Pension costs `jenv-bw2-i:PensionCosts`	85
Other expenses of employee benefits `rj-i:EmployeeBenefitsExpensesOther`	86
Expenses of employee benefits excluding external employees `rj-i:EmployeeBenefitsExpensesExcludingExternalEmployees`	87
Expenses of external employees `rj-i:ExternalEmployeesExpenses`	88
Amortisation of intangible assets `jenv-bw2-i:AmortisationIntangibleAssets`	89
Depreciation of property, plant and equipment `jenv-bw2-i:DepreciationPropertyPlantEquipment`	90
General expenses `rj-i:GeneralExpenses`	91
Food and hospitality expenses `rj-i:FoodAndHospitalityExpenses`	92
Patient and residents dependent expenses `rj-i:PatientAndResidentsDependentExpenses`	93
Maintenance and energy expenses `rj-i:MaintenanceAndEnergyExpenses`	94
Rental and leasing expenses `rj-i:RentalLeasingExpenses`	95
Additions to provisions `rj-i:AdditionsProvisions`	96
Interest income `rj-i:InterestIncome`	97
Share in results of participating interests `jenv-bw2-i:ShareInResultsParticipatingInterests`	98
Changes in the value of financial assets and of securities that are part of the current assets `jenv-bw2-i:ChangesValueFinancialAssetsSecurities`	99
Other income from financial assets and securities `rj-i:IncomeOtherFinancialAssetsSecurities`	100
Interest expenses `rj-i:InterestExpenses`	101
Financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRates`	102
Movement of financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesMovement`	103
Financing difference during the period of the financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesFinancingDifferenceDuringPeriod`	104
Corrections from previous years of the financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesCorrectionsPreviousYears`	105
Payments (receipts) of financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesPaymentsReceipts`	106
Stage of adoption of financing deficit/surplus to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesStageOfAdoption`	107
Debts due to financing surplus `rj-i:FinancingDeficitSurplusToBeSettledInRatesIncludedInLiabilitiesFinancingSurplus`	108
Receivables from financing deficit `rj-i:FinancingDeficitSurplusToBeSettledInRatesIncludedInReceivablesFinancingDeficit`	109
Legal budget for acceptable costs `rj-i:IncomeLegalBudgetAcceptableCosts`	110
Fees to cover the legal budget for acceptable costs `rj-i:FeesToCoverLegalBudgetAcceptableCosts`	111
Financing deficit surplus `rj-i:FinancingDeficitSurplus`	112
Disclosure of the amount that forms the basis for the levy under the macro-control instrument `rj-i:MacroControlInstrumentTaxableBasisDisclosure`	113
Amount constituting the basis for the levy under the macro-control instrument `rj-i:MacroControlInstrumentTaxableBasis`	114
Staffing level `rj-i:StaffingLevel`	115
Disclosure of staffing level `rj-i:StaffingLevelDisclosure`	116
Statement of the destination of the profit or the processing of the loss `jenv-bw2-i:ResultsAppropriationDisclosure`	117
Disclosure of joint ventures `rj-i:JointVenturesDisclosure`	118
Names and addresses of the other participants in the joint venture `rj-i:JointVenturesOtherPartiesDescription`	119
Description of the activities of the joint ventures `rj-i:JointVenturesActivitiesDescription`	120
Description of the administrative relations of the joint ventures `rj-i:JointVenturesAdministrativeRelationsDescription`	121
Description of the composition of the board and the supervisory body of the joint ventures `rj-i:JointVenturesCompositionManagementSupervisoryBodyDescription`	122
Description of the exemption of consolidation in connection with the application of Section 2:408 `jenv-bw2-i:ConsolidationExemptionDescription`	123
Equity in the separate financial statements `jenv-bw2-i:EquitySeparateFinancialStatements`	124
Equity in the consolidated financial statements `jenv-bw2-i:EquityConsolidatedFinancialStatements`	125
Difference in equity in the separate and consolidated financial statements `jenv-bw2-i:EquityDifferenceSeparateConsolidatedFinancialStatements`	126
Disclosure of differences in the equity and result between the separate and consolidated financial statements `jenv-bw2-i:DifferencesEquityResultSeparateConsolidatedFinancialStatementsDisclosure`	127
Disclosure of information on funding parameters that are important for the granting of the government grant from the Ministry of Education, Culture and Science over the reporting year `rj-i:CentralGovernmentContributionsWorkplaceFunctionMedicalFacultyUMCsDisclosure`	128